Roche's IMpower130 Met Co-Primary Endpoints, Lifting ASCO Suspense

 
• By Sten Stovall
  
Doctor examining at lungs radiograph x-ray film of patient in operation room. medical concept.
Roche Says Tecentriq In IMpower130 Met OS and PFS Co-Primary Endpoints • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer